Imugene Limited (IUGNF)

Imugene Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 17, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	34	64	278	389	727	1,321
Market Cap Growth	-79.63%	-77.14%	-28.44%	-46.52%	-44.93%	1294.40%
Enterprise Value	28	52	190	281	646	1,296
Last Close Price	0.14	0.34	1.14	2.02	4.59	9.29
PS Ratio	12.99	22.08	83.95	49.63	81.41	243.63
PB Ratio	1.22	2.16	3.53	3.08	7.61	27.10
P/TBV Ratio	3.39	7.28	4.96	3.67	9.96	58.48
EV/Sales Ratio	9.91	17.99	57.21	35.90	72.28	239.09
Debt / Equity Ratio	0.12	0.24	0.01	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.22	-0.25	-0.78	-0.80	-0.71	-0.45
Net Debt / EBITDA Ratio	0.20	0.17	0.67	4.09	2.80	1.77
Net Debt / FCF Ratio	0.15	0.14	0.84	4.85	3.19	2.18
Asset Turnover	0.04	0.04	0.03	0.07	0.12	0.11
Quick Ratio	1.02	1.44	3.61	27.16	15.17	8.11
Current Ratio	1.78	1.89	3.86	27.23	15.32	8.15
Return on Equity (ROE)	-111.28%	-84.54%	-97.23%	-23.10%	-37.18%	-29.57%
Return on Assets (ROA)	-39.22%	-37.27%	-50.87%	-14.33%	-21.48%	-16.82%
Return on Capital Employed (ROCE)	-119.70%	-114.00%	-116.20%	-20.70%	-26.90%	-27.40%
Earnings Yield	-114.21%	-71.10%	-35.88%	-6.49%	-3.59%	-1.05%
FCF Yield	-116.49%	-85.63%	-26.08%	-5.38%	-2.95%	-0.76%
Buyback Yield / Dilution	-18.24%	-4.90%	-12.96%	-11.33%	-20.88%	-14.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.